Save time and jump to the most important pieces.
GUELPH, ON / ACCESSWIRE / November 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has received a $1.1 million Government of Canada contract to test its multivalent aptamer technology for the rapid drug discovery of therapeutics or prophylactics of highly pathogenic avian influenza ("HPAI") A(H5N1).Highlights:The Government of Canada has identified the life sciences sector as a priority of the Canadian economy and is seeking advanced medical technology solutions to address ongoing challengesTriera was awarded a $1.1 million Government of Canada R&D contract through Innovation, Science and
GUELPH, ON / ACCESSWIRE / October 31, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it has withdrawn its submission to the Health Canada Pest Management Regulatory Agency ("PMRA") for its ZenGUARD™ Enhanced Air Filters. Based on feedback received from PMRA, and continued analysis of the Canadian regulatory environment, the Company believes there are other, more cost-effective, and timely pathways, to bring ZenGUARD™ Enhanced Air Filters to market in Canada. The Company has been evaluating and planning for these potential alternative options in parallel with the PMRA assessment process
GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™Antimicrobial Surgical Masks.As previously announced on July 24, 2024, the Company embarked on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. ("Henry Schein") that saw ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers across Canada. As a result of this program and the unique value proposition ZenGUARD™ Antimicrobial Surgical Masks bring to denta
GUELPH, ON / ACCESSWIRE / November 15, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the development of a significant upgrade to its aptamer platform improving the binding affinity of the universal Covid-19 aptamer from 300 to over 500 times, compared to the base aptamer. The improved platform has also solved key challenges for manufacturing and these High-Binding Affinity (HBA) aptamers are now produced with approximately a 95% yield. A key roadblock of translating a promising lead candidate (lab-scale therapeutic) into a commercial product is cost-effective and high-purity manu
GUELPH, ON / ACCESSWIRE / October 5, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the launch of a wholly-owned subsidiary that will own the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University. This licensing agreement includes the rapid-detection platform and the recent aptamer-based platform technology developed by Dr. Yingfu Li and his team that is showing promise as a therapeutic through preclinical studies being conducted by Dr. Matthew Miller and his team. This new entity has been launched as a vehicle to accel
GUELPH, ON / ACCESSWIRE / January 12, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK);(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Mr. Mitch Swergold as its Director of Investor Relations.Mr. Swergold earned a Bachelor of Arts in Political Science from Columbia University in the City of New York, and a Juris Doctor degree from Emory University School of Law. After practicing law and serving as a research analyst at two investment banks, Mr. Swergold was a Senior Analyst and Portfolio Manager at various hedge funds, focusing on technology and macroeconomic investing."Mitch's experience investing in technology companies, from early to la
6-K - Zentek Ltd. (0001904501) (Filer)
6-K - Zentek Ltd. (0001904501) (Filer)
6-K - Zentek Ltd. (0001904501) (Filer)
On Monday, 369 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows: Danaher (NYSE:DHR) was the biggest company by market cap to set a new 52-week low. The smallest company in terms of market cap to set a new 52-week low was Ascent Solar Technologies (NASDAQ:ASTI). EBET (NASDAQ:EBET) saw the largest move of the companies, as shares plummetted 2955.38% to hit a new 52-week low. Fiserv (NYSE:FI) was the most promising stock of the group, with shares actually trading up 0.0% to bounce back after reaching its new 52-week low. Here are all the stocks that set new 52-week lows as of 10am on Monday: Danaher (NYSE:DHR) stock set a new 52-week low of $210.14 on M
On Tuesday, 386 stocks made new 52-week lows. Interesting Points From Today's 52-Week Lows: Diageo (NYSE:DEO) was the largest firm by market cap to set a new 52-week low. Neptune Wellness Solns (NASDAQ:NEPT) was the smallest company by market cap to set a new 52-week low. Vaccinex (NASDAQ:VCNX)'s stock came under the most pressure, trading down 1227.51% to reach a new 52-week low. Nouveau Monde Graphite (NYSE:NMG) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low. Stocks dropping to new 52-week lows on Tuesday: Diageo (NYSE:DEO) stock broke to a new 52-week low of $151.08 on Tuesday. Shares of the company trade